May 23, 2018
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
May 15, 2018
As submissions complexity intensifies, the key to better resource management is better measurement, writes Adrian Leibert.
May 14, 2018
After months of expectations and repeated delays, President Trump formally announced his strategy for making prescription medicines more affordable and accessible in the U.S.
May 11, 2018
Ashley Slavik outlines the preparations for the new EU data protection regulation, and what others can learn from the experience
May 09, 2018
Pharmaceutical Executive
Pharm Exec interviews the FDA commissioner, who is building support by combating opioid abuse and advancing innovation.
May 02, 2018
From BioPharm International
Public health authorities and the biomedical research community are seeking new strategies to address global health threats, writes Jill Wechsler.
Apr 26, 2018
Pharmaceutical Executive
Prashant Dhanavade discusses the impact, challenges and the importance of ensuring readiness with ICH E2B (R3) EudraVigilance.
Apr 04, 2018
FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion. Jill Wechsler reports.
Mar 29, 2018
After months of delay, Congress finally passed a $1.3 trillion omnibus budget bill March 22, 2018, just in time to avoid another government shut-down.
Mar 08, 2018
As part of FDA initiatives to reward innovation and promote patient access to medicines, the agency is working hard to support the development of high quality biosimilars and interchangeable products, Scott Gottlieb told a conference on March 7.
lorem ipsum